Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Genes Dev ; 29(1): 7-22, 2015 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-25504365

RESUMO

Long-term exposure to peroxisome proliferator-activated receptor γ (PPARγ) agonists such as rosiglitazone induces browning of rodent and human adipocytes; however, the transcriptional mechanisms governing this phenotypic switch in adipocytes are largely unknown. Here we show that rosiglitazone-induced browning of human adipocytes activates a comprehensive gene program that leads to increased mitochondrial oxidative capacity. Once induced, this gene program and oxidative capacity are maintained independently of rosiglitazone, suggesting that additional browning factors are activated. Browning triggers reprogramming of PPARγ binding, leading to the formation of PPARγ "superenhancers" that are selective for brown-in-white (brite) adipocytes. These are highly associated with key brite-selective genes. Based on such an association, we identified an evolutionarily conserved metabolic regulator, Kruppel-like factor 11 (KLF11), as a novel browning transcription factor in human adipocytes that is required for rosiglitazone-induced browning, including the increase in mitochondrial oxidative capacity. KLF11 is directly induced by PPARγ and appears to cooperate with PPARγ in a feed-forward manner to activate and maintain the brite-selective gene program.


Assuntos
Adipócitos/metabolismo , Proteínas de Ciclo Celular/metabolismo , PPAR gama/genética , PPAR gama/metabolismo , Proteínas Repressoras/metabolismo , Adipócitos/citologia , Adipócitos/efeitos dos fármacos , Adipócitos Marrons/citologia , Proteínas Reguladoras de Apoptose , Proteínas de Ciclo Celular/genética , Reprogramação Celular , Cromatina/metabolismo , Regulação da Expressão Gênica , Humanos , Hipoglicemiantes/farmacologia , Mitocôndrias/efeitos dos fármacos , Oxirredução , Ligação Proteica , Proteínas Repressoras/genética , Rosiglitazona , Tiazolidinedionas/farmacologia , Ativação Transcricional/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...